𝘋𝘳 𝘈𝘨𝘢𝘳𝘸𝘢𝘭’𝘴 𝘏𝘦𝘢𝘭𝘵𝘩 𝘊𝘢𝘳𝘦'𝘴 𝘐𝘗𝘖 𝘖𝘱𝘦𝘯𝘴 𝘰𝘯 𝘑𝘢𝘯 29; 𝘛𝘰 𝘳𝘢𝘪𝘴𝘦 𝘙𝘴 300 𝘤𝘳𝘰𝘳𝘦 𝘵𝘩𝘳𝘰𝘶𝘨𝘩 𝘐𝘗𝘖

  • Opens on Wednesday, January 29, 2025, price band set at ₹382/- to ₹402/- per Equity Share

Chennai, January 24, 2025: Dr. Agarwal’s Health Care Limited, a trusted brand in the eye care services industry and according to the CRISIL MI&A Report is India’s largest eye care service chain by revenue from operations for FY2024, has fixed the price band of ₹382/- to ₹402/- per Equity Share of face value ₹1/- each.

Dr Agarwal’s Health Care's IPO Opens on Jan 29; To raise Rs 300 crore through IPO

The Initial Public Offering (“IPO” or “Offer”) of the Company will open on Wednesday, January 29, 2025, for subscription and close on Friday, January 31, 2025. Investors can bid for a minimum of 35 Equity Shares and in multiples of 35 Equity Shares thereafter. The issue has an employee reservation portion of up to 1,579,399 equity shares and shareholders reservation of up to 1,129,574 equity shares.

The IPO is a mix of fresh issue of up to Rs 300 crore and an offer of sale up to 67,842,284 equity shares by Promoters, Investors, and Other Selling Shareholders. The proceeds from its fresh issuance to the extent of Rs 195 crore will be utilized for repayment/ prepayment in part or full of certain of its borrowings; and the balance proceeds will be utilized for general corporate purposes and unidentified inorganic acquisitions.

Dr. Agarwal’s Health Care, provides end-to-end comprehensive eye care services, including cataract, refractive and other surgeries; consultations, diagnoses and non-surgical treatments; and sells opticals, contact lenses and accessories, and eye care related pharmaceutical products through its network of 209 Facilities as of September 30, 2024. According to a CRISIL MI&A Report cited in its red herring prospectus, the company held about 25% of the total eye care service chain market in India as of FY2024.

As of September 30, 2024, the Company operates 193 facilities in India across 117 metro and non-metro cities spanning 14 states and four union territories, along with 16 facilities spread across nine countries in Africa. The Company operates through a hub-and-spoke and asset light operating model. According to the CRISIL MI&A Report, the Company has a diversified presence, with 70 facilities located in Tier-I cities and 123 facilities in other cities across India.

Dr. Agarwal’s Health Care, under the aegis of its Chairman, Dr. Amar Agarwal, who has over 35 years of clinical experience in the eye care services industry, has pioneered multiple surgical innovations in ophthalmology and has published several papers in reputed scientific journals globally. Some key surgical capabilities of Dr. Agarwal’s Health Care includes intraocular lens procedures, cornea transplantation, pinhole pupilloplasty, single pass four-throw pupilloplasty and LASIK surgeries.

Kotak Mahindra Capital Company Limited, Morgan Stanley India Company Private Limited, Jefferies India Private Limited, Motilal Oswal Investment Advisors Limited are the book-running lead managers, and KFin Technologies Limited is the registrar of the issue.

The Issue is being made through the book-building process, wherein not more than 50% of the issue shall be available for allocation on a proportionate basis to qualified institutional buyers, not less than 15% and 35% of the offer shall be available for allocation to non-institutional investors, and retail individual bidders respectively.

****

Popular posts from this blog

மக்கள் படை கட்சியின் 2026 சட்டமன்ற வேட்பாளர் பட்டியல் வெளியீடு – பொதுச் செயலாளர் ராம்பிரகாஷ் அறிவிப்பு

THANC Hospital Opens 'Chennai Breast Centre' | Focuses on Women's Health & Breast Cancer Awareness

𝘊𝘩𝘦𝘯𝘯𝘢𝘪 𝘏𝘰𝘴𝘵𝘴 64𝘵𝘩 𝘈𝘎𝘔 & 𝘕𝘢𝘵𝘪𝘰𝘯𝘢𝘭 𝘊𝘰𝘯𝘧𝘦𝘳𝘦𝘯𝘤𝘦 𝘰𝘧 𝘍𝘦𝘥𝘦𝘳𝘢𝘵𝘪𝘰𝘯 𝘰𝘧 𝘗𝘢𝘱𝘦𝘳 𝘛𝘳𝘢𝘥𝘦𝘳𝘴 𝘈𝘴𝘴𝘰𝘤𝘪𝘢𝘵𝘪𝘰𝘯𝘴 𝘰𝘧 𝘐𝘯𝘥𝘪𝘢 (𝘍𝘗𝘛𝘈)

𝘒𝘢𝘶𝘷𝘦𝘳𝘺 𝘏𝘰𝘴𝘱𝘪𝘵𝘢𝘭 𝘝𝘢𝘥𝘢𝘱𝘢𝘭𝘢𝘯𝘪 𝘐𝘯𝘵𝘳𝘰𝘥𝘶𝘤𝘦𝘴 𝘍𝘳𝘦𝘦 𝘔𝘰𝘣𝘪𝘭𝘦 𝘓𝘶𝘯𝘨 𝘊𝘭𝘪𝘯𝘪𝘤 – “𝘒𝘢𝘶𝘷𝘦𝘳𝘺 𝘉𝘳𝘦𝘢𝘵𝘩 𝘊𝘩𝘦𝘤𝘬” 𝘧𝘰𝘳 𝘊𝘩𝘦𝘯𝘯𝘢𝘪 & 𝘚𝘶𝘳𝘳𝘰𝘶𝘯𝘥𝘪𝘯𝘨 𝘈𝘳𝘦𝘢𝘴

𝘗𝘢𝘶𝘭𝘴𝘰𝘯𝘴 𝘉𝘦𝘢𝘶𝘵𝘺 & 𝘍𝘢𝘴𝘩𝘪𝘰𝘯 𝘗𝘷𝘵. 𝘓𝘵𝘥. 𝘜𝘯𝘷𝘦𝘪𝘭𝘴 𝘗𝘪𝘯𝘬 𝘗𝘰𝘵𝘢𝘵𝘰 – 𝘈 𝘊𝘩𝘪𝘤 𝘝𝘦𝘨𝘦𝘵𝘢𝘳𝘪𝘢𝘯 𝘋𝘪𝘯𝘪𝘯𝘨 𝘋𝘦𝘴𝘵𝘪𝘯𝘢𝘵𝘪𝘰𝘯 𝘪𝘯 𝘗𝘰𝘦𝘴 𝘎𝘢𝘳𝘥𝘦𝘯